COMMUNIQUÉS West-GlobeNewswire

Korro Announces $70 Million Private Placement
18/04/2024
Financing led by Deep Track Capital with participation from other leading healthcare investors Pro-forma cash and cash equivalents of approximately $236 million before fees and expenses On track for regulatory filing [...]
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
18/04/2024
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and [...]
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
18/04/2024
Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a [...]
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
18/04/2024
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent Fingerprinting acquisition NEW [...]
Lexicon Pharmaceuticals to Host 2024 Investor Day
18/04/2024
Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic Pain THE WOODLANDS, Texas, April 18, 2024 [...]
BiomX Announces the Appointment of Susan Blum to its Board of Directors
18/04/2024
CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies [...]
Windtree Therapeutics Announces Reverse Stock Split
18/04/2024
WARRINGTON, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for [...]
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
18/04/2024
Additionally, the Company announced approval of the non-proprietary name “bezisterim” for NE3107 CARSON CITY, Nev., April 18, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical- [...]
Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation
18/04/2024
Proceeds Will Help Protect Oceans, Waves and Beaches for All People to Enjoy MONTAUK, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Montauk Brewing Company (“Montauk Brewing” or “Montauk”), the leading and fastest-selling [...]
Canadian Men's Health Foundation names Kenton Boston as President & CEO
18/04/2024
VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- The Canadian Men’s Health Foundation ’s (CMHF) board of directors is proud to announce the appointment of Kenton Boston as President & Chief Executive [...]
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
18/04/2024
WILMETTE, Ill., April 18, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced [...]
23andMe announces CEO’s intention to pursue a potential take-private
18/04/2024
SOUTH SAN FRANCISCO, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, has been made aware that Anne Wojcicki, Chief Executive Officer, [...]
Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA
18/04/2024
• Demonstration of Volta AF-Xplorer™ at Heart Rhythm Society (HRS) 2024, May 16-19 • Dr. Andrea Natale, a world recognized leader in the field of electrophysiology, to moderate Rhythm Theater MARSEILLE, France, April 18 [...]
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
18/04/2024
Media Release Centre for Human Drug Research (CHDR) will conduct Phase I trial to evaluate IMP761, a first-in-class LAG-3 agonist antibody designed to restore balance to the immune system and address the underlying [...]
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
18/04/2024
LANGHORNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
American Shared Hospital Services Strengthens Senior Management Structure
18/04/2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced [...]
Panbela Announces Poster Presentation at American Association for Cancer Research:
18/04/2024
Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models MINNEAPOLIS, April 18, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA)(“Panbela”), [...]
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
18/04/2024
Noah Medical white papers based on data collected from D. Kyle Hogarth, MD and Amit Mahajan, MD demonstrate power of integrated Imaging to overcome CT-to-body divergence in navigated bronchoscopy SAN CARLOS, Calif., [...]
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
18/04/2024
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and [...]

Pages